This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The launch of ChatGPT in November 2022 set off a generativeAI gold rush, with companies scrambling to adopt the technology and demonstrate innovation. Legacy chatbots, product recommendation engines, and several other useful tools may rely only on earlier forms of AI.
Qventus platform tries to address operational inefficiencies in both inpatient and outpatient settings using generativeAI, machine learning and behavioural science. Related reading: The Weeks Biggest Funding Rounds: Data Storage And Lots Of Biotech Illustration: Dom Guzman The round was led by Kleiner Perkins.
AI and proteins have been in the news lately, but largely because of the efforts of research outfits like DeepMind and Baker Lab. Their machine learning models take in easily collected RNA sequence data and predict the structure a protein will take — a step that used to take weeks and expensive special equipment. Image Credits: Cradle.
billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. Yet even amid the hottest period ever for AI funding , investment in AI-enabled health startups has remained below 2021 levels.
The new round is bigger than the $6 billion round Elon Musk ’s generativeAI startup, xAI , officially announced in May, which up to this point was the largest round raised this year. Pacific Fusion , $900M, energy: Another huge AI-related round. Well, Crusoe has now turned its energy to AI — literally.
This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 billion across 110 Series A rounds, per Crunchbase data. Of the 10 largest Series A rounds this year, six are biotechs.
Last month, xAI and Anthropic raised a combined $9 billion as AI funding remained red-hot. xAI , $5B, artificial intelligence: GenerativeAI startup xAI raised $5 billion in a round valuing it at $50 billion, The Wall Street Journal reported. While a cybersecurity company, Cyera is certainly riding the AI wave.
Of course, it was led by two well-known AI startups — including xAI , which had its second massive haul of cash in just six months. xAI , $5B, artificial intelligence: GenerativeAI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported.
Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.
Suggestions like “listen to your customers” and “make data-driven decisions” are so general, they’re hard to implement. “While excessive or unhelpful customer data can clog content pipelines, the right information can power hyper-personalization at scale,” he writes.
We featured generativeAI companies five years before the popular investors took notice and climate tech 2.0 It’s a big new data rush. Clean tech – Tied in with the biotech trend, we’re seeing a continued surge in input/output companies that process waste to produce byproducts like energy and potable water.
Stability AI , the venture-backed startup behind the text-to-image AI system Stable Diffusion, is funding a wide-ranging effort to apply AI to the frontiers of biotech. Diffusion models — which underpin image generators like Stable Diffusion and OpenAI’s DALL-E 2 — create new data (e.g.
The retail industry has no shortage of cases on display where generativeAI has shown tangible benefits. They had ChatGPT write the script, and other gen AI tools to create a digital person who reads the script, a scalable process with at least one measurable benefit: speed. And software code is a language.”
Not surprisingly AI led the way — as it always seems to do — with a trio of a billion-or-more rounds. xAI , $6B, artificial intelligence: Elon Musk ’s generativeAI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generativeAI company in the world behind only competitor OpenAI.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note.
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. Data security startup Cyera raised a $300 million Series C led by Coatue at a $1.4 Let’s take a look.
Eight startups raised $100 million or more this week as a biotech and financial services company led the way. Yep, no huge AI raise. With the new rounds, global venture dollars in defense tech this year has now passed $1 billion, per Crunchbase data. Scorpion Therapeutics , $150M, biotech: Yet another big biotech round.
Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical Applications Capgemini Nov 6, 2024 Facebook Linkedin The BioTechX event in Basel in October was a major gathering for biotech and pharma professionals. Last year, we were all about the potential of large language models and generativeAI.
Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. Rivos , $250M, semiconductor: Semiconductor startups are seeing big money, in part thanks to the explosion in generativeAI.
The firm has also been one of the more active multistage venture investors since the second half of 2022 when venture funding slowed, based on an analysis of Crunchbase data. Andreessen co-led the Series B in AI voice software developer ElevenLabs with angel investors Nat Friedman and Daniel Gross. dollars unless otherwise noted.
Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. Scale AI , $1B, artificial intelligence: This week was like many — one topped with a big AI round. based AI startup this month, after CoreWeave raised a whopping $1.1
xAI , $6B, artificial intelligence: Elon Musk ’s generativeAI startup, xAI, officially announced its long-awaited fundraise — making it the second-most-valuable generativeAI company in the world behind only competitor OpenAI. Grok is trained off data from another Musk-owned company, X, formerly Twitter.
Pika is part of a growing group of startups building text-to-video AI software. tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. The startup plays at a unique intersection of healthcare/biotech, AI and 3D technology.
The new round is bigger than the $6 billion round Elon Musk ’s generativeAI startup, xAI , officially announced in May — which was the largest round raised this year. Kailera Therapeutics , $400M, biotech: Biotech was even bigger this week than normal. Poolside has raised $626 million since being founded in May 2023.
While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Celestial AI , $175M, semiconductors: Optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.
Global venture capital funding reached just over $22 billion in April 2024 — flat month over month and up a few percentage points year over year — Crunchbase data shows. The slowdown in venture funding has continued despite the AI technology wave that has washed over startups in the past few years. AI companies raised $3.9
Formation Bio , $372M, biotech: Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. Founded in 2011, the company has raised $1.4 billion, per Crunchbase.
Investors certainly put their money everywhere, from biotech to productivity tools, but they didn’t shell out a lot. Grafana’s open-source software platform helps monitor and visualize data. Founded in 2014, the company has now raised more than $805 million, according to Crunchbase data.
Energy and data centers seem to be on everyone’s mind right now — and this week’s list bears that out. Lightmatter , $400M, data centers: Lightmatter, a startup that uses light to link chips together and to do calculations for the deep learning necessary for AI, locked up a $400 million Series D led by new investor T.
You had to raise more than $150 million to make the top 10 list this month — as investors put money into everything from defense tech to semiconductors to biotech. billion in 2024, per Crunchbase data. Groq , $640M, semiconductor: AI semiconductor and software startup Groq locked up a $640 million Series D round at a valuation of $2.8
While we saw enthusiasm for hot sectors like generativeAI, it was tempered by pullbacks in areas ranging from fintech to consumer products. In addition to AI, cleantech, biotech and next-generation manufacturing were among the areas where startups scored outsized rounds. Data reported is as of Jan.
That included more than $200 million for a security company and lots of big biotech raises. Founded in 1991, the Fortnite creator has raised nearly $8 billion to date, according to Crunchbase data. NinjaOne , $232M, security : NinjaOne showed this week that not all big funding rounds go to generativeAI companies.
Last quarter was a great quarter if you were a founder of an AI-related startup looking for funding — maybe. billion in 1,001 deals, per Crunchbase data. billion go to AI startups — a 24% increase from the $28.7 Such startups saw more money in 2Q than they ever have before, raising a whopping $24.2 billion in H1 last year.
It seems every time a large generativeAI company raises billions of dollars, one of the Big Tech pillars such as Nvidia , Microsoft or Google is leading the round. However, a look at Crunchbase data shows something surprising — corporate venture investments were actually down throughout the past two years.
There was a time when raising over a billion dollars as an AI startup was enough to warrant a little name recognition. Per Crunchbase data , there were at least 23 private, AI-focused startups* funded in the past couple years that have raised over $1 billion in equity financing to date. Not anymore.
Then just this week, the AI giant bought video collaboration startup Multi , previously Remotion, in what was reportedly an acqui-hire. Overall, M&A has picked up slightly involving startups, per Crunchbase data. MEandMine , a developer of AI-flagging to identify psychological risks in young children, raised $4.5
billion — was invested in companies with at least one female founder, Crunchbase data shows. The uptick in the portion of startup investment going to female-founded companies — up from 15% in 2022 — was in large part due to a number of billion-dollar-plus rounds raised by AI companies with a female co-founder.
Founded in 1991, the Fortnite creator has raised nearly $8 billion to date, according to Crunchbase data. The round marks the largest by an AI startup this year, per Crunchbase data. Freenome , $254M, biotech: This is just one of many big biotech raises this month. billion valuation.
Converge Bio, a generativeAI platform for accelerated drug discovery and development, announced on Wednesday that it has raised $5.5 million in Seed funding, led by TLV Partners. in Seed funding to speed up drug discovery and development with GenAI appeared first on OODAloop.
Here at Crunchbase News, we have our own future-telling tool: Seed-funding data. It wasn’t surprising, for instance, to see that generativeAI has been a popular area for seed investors. AI-enabled healthcare There’s a lot of funding for nascent companies at the intersection of artificial intelligence and healthcare.
billion, per Crunchbase data. Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generativeAI startup. AI enterprise conversational platform Kore.ai Big global deals While Generate and Recurrent topped all rounds worldwide, there was a big round abroad. billion in October 2022.
For a time — especially in the middle of the year — it seemed like nine-figure rounds were being thrown out by investors every week to the latest and greatest AI startup. Per Crunchbase data , there were eight deals of at least a half-billion dollars or more consummated this year involving AI startups. billion in June.
billion in Q1 of 2024, per Crunchbase data. Per Crunchbase data, investors participated in 2,435 known rounds at all stages in the course of the quarter. Altogether, $19 billion went into late-stage and technology growth rounds in North America in Q1, per Crunchbase data. billion — surpassing the prior two quarters.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content